chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I developed a mild itchy rash over several days that has spread on my back, chest, stomach, arms, and inner thighs.  It's on both sides of my body.; next 7 days a rash resembling chicken pox started across my trunk, arms, legs, outer thighs, then inner thighs, arms -outer than inner - always bilateral. Scabs formed. 100% like chicken pox.; itch lower back + both shoulders; Scabs; This is a spontaneous report from a contactable other healthcare professional (Patient). A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9261), via an unspecified route of administration, administered in left arm on 10Feb2021 at 15:30 (at the age of 49-years-old) as dose 1, single dose for COVID-19 immunization. Medical history included penicillin allergy with hives, high blood pressure, rosacea, known allergies: environmental and childhood eczema. Patient did not receive any other vaccine in four weeks within four weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN), both for an unspecified indication, from an unspecified date and unknown if ongoing. On 10Feb2021 at 20:00 (same day as vaccination), patient developed a mild itchy rash over several days that has spread on her back, chest, stomach, arms, inner thighs. It's on both sides of my body. The patient had to visit Doctor or other healthcare professional office/clinic for the events. Post the vaccination, the patient had not been tested for COVID-19. On 25Jun2021, it was reported that on first dose, the evening of vaccination: Started to itch lower back + both shoulders. Over the course of the next 7 days a rash resembling chicken pox started across trunk, arms, legs, outer thighs, then inner thighs, arms -outer than inner - always bilateral. Scabs formed. 100% like chicken pox. They saw a doctor. Doctor was puzzled. Vitals normal, no fever. The patient has not seen in the Emergency department. The patient was not hospitalized and admitted in Intensive Care Unit. Multi organ involvement: Dermatological/Mucosal  checked. The patient had generalized pruritus with skin rash. It was reported that exactly like a chicken pox rash. Each patch resolved over 7-8 days, 14-15 days until completely of cured. So itchy rash went before crusting over. Bilateral - rash erupted in both sides of body at the same time. Face, lower legs never got a rash (nor hands/feet). The event did not require the initiation of new medication or other treatment or procedure. The outcome for the events was resolved on 2021.   Follow-up attempts completed. No further information expected  Follow up (25Jun2021): New information received from a contactable other HCP. This other HCP (patient) reported in response to letter sent via follow-up activity which included that: vaccination time updated, second dose details added in narrative, New events added (chicken pox, Scabs, itch lower back + both shoulders), outcome updated.  Follow-up attempts completed. No further information expected
Shortly after the injection, I was experiencing shoulder pain and reduced mobility.  I didn't think much about it, assumed it would go away.  Over the last 4 days, the pain, weakening and reduced mobility have progressively increased.  I have taken OTC pain medication and anti-inflammatory meds.
7 days after administration developed pruritic, maculo-papular erythematous rash, mostly on the back. Required an Urgent Care visit and treatment with cortisone injection and methyl prednisolone x 7 days and hydroxyzine HCL 25 mg tid.
The day after receiving dose 4 I began to have a headache and my blood pressure spiked to 174/93.  I consulted my doctor and I have monitored my blood pressure twice daily.  I continue to have the headache and feel fatigued.
patient had rash on torso and abdomen day after shot as well as the high temp (103) and nausea, patient tolerated first 2 vaccines in series fine, rash on torso has gone away but still has rash near injection site (11/9/21)
13 year old female patient was vaccinated with the above vaccines. Patient was seated for approximately 3-5 minutes post vaccination and then stood and walked approximately 5 feet and then walked back, during which time she was talking. She stood for approximately 2-3 minutes after walking back and then fainted, falling to the floor. Patient was placed in chair and ice was applied and pressure placed to cut to chin area. Cut measured approximately 1 inch. Patient also stated that felt right side lower back tooth (2nd to last) felt loose. Also stated she had a headache and felt dizzy. Patient was accompanied by Aunt (who is her guardian) to clinic and Aunt was encouraged to take patient to clinic or hospital for possible need of stitches and evaluation of possible concussion. Patient was helped into wheelchair and wheeled to Aunt's awaiting care at front of clinic. Patient left clinic accompanied by Aunt and Uncle. On October 1, 2018, two messages were left with no response. On October 2, I spoke with Aunt. Aunt states she immediately took patient to be evaluated. She states that an EEG was done and that she received stitches to her chin. She was also given medication for pain. She states patient returned to school today but continues with soreness to jaw and loose tooth. She states she will have the tooth evaluated after the patient's stitches are removed.
On April 18, 2021, nine days after the person got his second dose of Moderna vaccine, he committed suicide using a gun in the presence  of his family.
No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 39-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients).    No concomitant drug was reported.  Patient ID was reported It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No treatment information was reported.
Sweating; slight trembles; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 01May2021 at 09:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 10Apr2021 at 09:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 10:00, the patient experienced sweating and slight trembles. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown if the patient received any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sweating and slight trembles was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
metallic taste in mouth,  headache , can't sleep, nausea, diarrhea,  loss of appetite,  little strength, fever, chills .  fever gone
Information has been received from a health professional concerning a 10 yr old white female, with no medical history and no allergies who on 24Nov95 was vaccinated with a first dose of varicella virus vaccine live (lot 610246/0444B). There was no illness at the time of vaccination and no adverse events following prior vaccination. It was reported that on 16Apr05 the pt experienced breakthrough chickenpox, during a middle school outbreak, that was described as mild with a total of 20 generalized bumps. The pt was afebrile. It was reported that the pt recovered. Medical attention was not sought. Additional information is not expected.
Headache, Myalgia, Arm pain/soreness, injection site redness Narrative:
Severe pain in stomach and to back the resulted in ER visit and hospital admission on 12/23 due to Pancreatitis and elevated liver enzymes. Dr stated tests show no other info and felt it could be a virus settled in pancreas and could not state if vaccine did or did not cause it.
This spontaneous report as received from a consumer (customer of the patient) refers to a female patient of unknown age. On an unknown date, the patient reported that "her/his hair dresser" was vaccinated with ZOSTAVAX (dose, duration and route were not reported). On an unknown date, the patient experienced shingles and the reporter could not get her/his hair done because her/his did not want to get shingles. The outcome of had shingles was unknown. Additional information is not expected.
headache, tired , low grade fever. I took Bayer asiprin and took it easy. It was after my 2nd Pfizer dose on 2/19/21  that I felt  notable affects. similar but stronger, Was very weak, fever 102.0 .. sore arm, very bad headache, some stomach nausea. lasted a full day. I did not call a doctor. I did call a local pharmacist to ask questions.
The pt experienced dizziness, aches, low grade fever, stiff neck, burning sensation in feet, Shortness of Breath, chest pain, severe headache, pressure behind eyes, thoughts are fuzzy, lack of concentration, slurred speech, weakness, fatigue, staggering gait.
Neck ache, back ache, headache and dizziness, 6 hours post vax. 24 hours later, had sore throat, malaise, dizziness and general body aches.
Patient tested positive for COVID 19 on 10/30/2021 symptoms reported: Fever 102.5, chills, sore throat, congestion, hoarseness, shortness of breath, cough
Vaccine was stored and administered beyond 30 days use by date; Vaccine was stored and administered beyond 30 days use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was stored and administered beyond 30 days use by date) and PRODUCT STORAGE ERROR (Vaccine was stored and administered beyond 30 days use by date) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was stored and administered beyond 30 days use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored and administered beyond 30 days use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was stored and administered beyond 30 days use by date) and PRODUCT STORAGE ERROR (Vaccine was stored and administered beyond 30 days use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. The vial was initially stored in the refrigerator on 27 May 2022. The vial did not undergo any temperature excursions.  It was reported that Route and Body site was deltoid. Treatment medication was not provided by the reporter.
Scalp tingling following injection slight nausea heartburn, thick feeling in back of throat. 50mg BENADRYL IM - Symptoms improved/resolved.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX. Indication, lot number, expiry date, route of administration and anatomical location were not reported. On an unknown date after the vaccination the patient experienced numbness (hospitalization). The outcome of numbness is unknown. The reporting pharmacist did not provide a causality statement. Additional information has been requested.
Fever 102.5 within 30 min SEVERE Chills at 3 am (4/2) Vomiting at 5 am Continued fever on 4/2 and 4/3 Slept 12 hours Severe diarrhea on 4/3 Fever broke at 3 pm on 4/3
Medical Information Potential AE; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Medical Information Potential AE) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) tablet for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient experienced IMMUNISATION REACTION (Medical Information Potential AE). At the time of the report, IMMUNISATION REACTION (Medical Information Potential AE) outcome was unknown.            No concomitant medications was reported. Patient received second booster dose 2 week ago and was querying was it still okay to take Paxlovid.  Paitient was taking Paxlovid and would like to ask for information regarding use with the antibiotic Doxycycline. No treatment medications was reported.   Reporter did not allow further contact
I felt very tired and worn out the entire next day. Just wanted to rest on the couch. Felt a bit dizzy. Also had to urinate frequently. On the second day after, I felt OK in the morning, but was wiped out again in the afternoon.
50-year-old female complaining of worsening shortness of breath with activity and mild chest pain for the past 2 days. Patient was diagnosed with Covid 19 on 11/11. She is fully vaccinated. Vital signs within normal limits.Patient discharged home with a pulse oximeter, referral for monoclonal antibody infusion. Instructed to return to the emergency room for worsening chest pain, shortness of breath, hypoxia.aspirin chew tab 324 mg given.
pt recv vax 12JUN96 & 1/2 hr p/vax pt noticed inc pain @ inj site;no fever-Ibuprofen did not help;pain radiated to neck-down the arm;noc of 12JUN96 exp diff using lt arm (site of inj) also noted bruise @ site;hematoma over inj site;numbness
Information has been received on 20-APR-2017 regarding a case in litigation from a lawyer and a consumer of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) subcutaneous on or about 07-AUG-2013, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 26-AUG-2013, the patient was treated for a painful rash that was diagnosed as shingles. Although shingles is an incurable viral condition, the patient was prescribed valacyclovir hydrochloride (VALTREX) and pregabalin (LYRICA) to manage her symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
hot flashes Narrative: She notes having experienced nausea, dizziness and hotflashes after the initial vaccination *Mild nausea started about 30 minutes after the vaccination once she was in the car driving home. She rested and had a bite to eat, after which the nausea resolved. It was not associated with vomiting or abdominal cramps. *Dizziness a/w hotflashes: started once she was at home. She was able to rest in an air conditioned room and drink water, which led to resolution of the sx about 30 min after onset. Patient denied s/sx concerning for immediate allergic reaction or swelling/angioedema.
Mild redness and swelling on left thigh around injection site, day after injection. Ice packs, diphenhydramine and ibuprofen as needed.
severe menstrual bleeding after menopause (8years ago); high fever - 103F; This spontaneous case was reported by a consumer and describes the occurrence of POSTMENOPAUSAL HAEMORRHAGE (severe menstrual bleeding after menopause (8years ago)) and PYREXIA (high fever - 103F) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Menopause since 2013.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced POSTMENOPAUSAL HAEMORRHAGE (severe menstrual bleeding after menopause (8years ago)) and PYREXIA (high fever - 103F). At the time of the report, POSTMENOPAUSAL HAEMORRHAGE (severe menstrual bleeding after menopause (8years ago)) and PYREXIA (high fever - 103F) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment included Advil. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.       On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5. On 06-Mar-2021, the patient experienced LIMB DISCOMFORT (sore arm). On 07-Apr-2021, the patient experienced POSTMENOPAUSAL HAEMORRHAGE (severe menstrual bleeding after menopause (8years ago)) (seriousness criterion medically significant) and PYREXIA (high fever - 103F). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 06-Apr-2021 at an unspecified dose and frequency. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported medication used for second dose reactions is ibuprofen.    This case was linked to MOD-2021-072661 (Patient Link).   This case was linked to MOD-2021-072661 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
couldn't move; feels sick to stomach; everything is hurting; sweating; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (couldn't move), ABDOMINAL PAIN UPPER (feels sick to stomach), PAIN (everything is hurting), HYPERHIDROSIS (sweating) and PYREXIA (fever) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOKINESIA (couldn't move), ABDOMINAL PAIN UPPER (feels sick to stomach), PAIN (everything is hurting), HYPERHIDROSIS (sweating), PYREXIA (fever) and HEADACHE (headache). At the time of the report, HYPOKINESIA (couldn't move), ABDOMINAL PAIN UPPER (feels sick to stomach), PAIN (everything is hurting), HYPERHIDROSIS (sweating), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included using a heated blanket.
Prolonged HA starting after receiving Pfizer COVID-19 vaccine on 29 Dec 2020-over 2 weeks. No fever/nausea/vomiting/photophobia/visual disturbances. Felt like a constant "vice grip". Not relieved with NSAIDS. Has a history of occasional migraines, but this HA presenting very differently. Resolved after 2 weeks. She did receive dose 2 on 1/19/2020 without recurrence of HA or ant concerning side effects.
Immediately after the vaccine I felt a terrible heat and I started to cough non-stop, the Paramedics checked me, gave me water and after 20 minutes of waiting I went out but I continued with the hot flashes, when I got home I felt suffocated, with nausea and a headache and then at night (4:00 PM) I felt super tired and in terrible pain, I couldn't stand up and my eyes couldn't open, the next day I had high fever, because of the intense pain I couldn't even grab a glass to drink water and I felt very cold. I was like this for 2 weeks. I called the doctor and they told me it was a reaction to the vaccine, they couldn't see me in person. They gave me medicine, I had a fever of 103. The sugar got out of control, I had dizziness. But then the bone pain persists and I take a muscle relaxant.
Patient stated after his first dose he felt dizzy, but went home and took a nap and felt fine when he woke up. After his second dose, we got up to check the date for his third and final dose, and within about two minutes of standing up he fell face first onto the ground. He came to within about 30 seconds (enough time for us to get EMS on the phone) and when he got up his face was very pale and greenish, and he sat down while medics came in to help. They did a check up on him, cleared him, and sent him home.